Clinical trial
A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast…
NCT00393497 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00393497 |
|---|---|
| Title | A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment |
| Official title | A Pilot Study of VEGF Inhibition in Patients With Lymphedema Following Breast Cancer Treatment |
| Lead sponsor | Indiana University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Lymphedema |
| Intervention type | Drug |
| Interventions | bevacizumab |
| Enrollment | 11 |
| Start date | Apr 1, 2007 |
| Primary completion | Oct 1, 2009 |
| Completion | Jan 1, 2011 |
| First posted | Oct 27, 2006 |
| Last update posted | Sep 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: